MedTrace Logo

Adding Dexmedetomidine to Bupivacaine for Bilateral Erector Spinae Block

NCT06231979 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2024-01-30

No results posted yet for this study

Summary

The aim of this study is to compare the analgesic effect of bilateral US-guided ESPB using bupivacaine alone versus bupivacaine and DEX in lumbar fusion surgeries.

Conditions

  • Erector Spinae Block
  • Lumbar Fusion Surgeries
  • Dexmedetomidine

Interventions

DRUG

Dexmedetomidine

1 μg/kg Dexmedetomidine per side in erector spinae block

DRUG

Bupivacain

18 mL of bupivacaine 0.25 % per side in erector spinae block

DRUG

Normal saline

2 ml normal saline 0.9% per side in erector spinae block

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-25
Primary Completion
2025-01-01
Completion
2025-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06231979 on ClinicalTrials.gov